Outcomes of shoulder arthroplasty following axillary lymph node dissection. 2019

Eric M Padegimas, and David Merkow, and Thema A Nicholson, and Mark D Lazarus, and Matthew L Ramsey, and Gerald R Williams, and Surena Namdari
Department of Orthopaedic Surgery, Thomas Jefferson University Hospitals, Philadelphia, USA.

BACKGROUND Shoulder arthroplasty with previous axillary lymph node dissection historically has unsatisfactory outcomes. We analyzed outcomes of primary shoulder arthroplasty in patients with previous axillary lymph node dissection. METHODS Thirty-two primary shoulder arthroplasties after prior axillary lymph node dissection were performed. These patients were analyzed for patient-reported outcomes, range of motion, complications, and reoperations. RESULTS Average age was 70.8 ± 7.5 years old. There were 19 anatomic total shoulder arthroplasties, four hemiarthroplasties, and nine reverse total shoulder arthroplasties. Eight were performed by a superior approach while 24 were performed by a deltopectoral approach with cephalic vein preservation. There were three complications (one deltoid dehiscence, one axillary nerve palsy, and one postoperative pneumonia). There was one revision (hemiarthroplasty to reverse total shoulder arthroplasty for cuff failure at 91 weeks), two reoperations, and no infections. Patient-reported outcomes were available for 21/26 (80.1%) of the surviving shoulders at 4.8 ± 2.0 years. Average visual analog scale pain score was 7.1 ± 14.5, Simple Shoulder Test score 8.3 ± 2.6 "yes" responses, Single Assessment Numeric Evaluation score 80.2 ± 17.4, and American Shoulder and Elbow Surgeons score 83.6 ± 14.1. CONCLUSIONS Axillary lymph node dissection is not a contraindication to shoulder arthroplasty. A deltopectoral exposure can be utilized without substantial risk of worsening lymphedema or wound complications. While a superior approach avoids cephalic vein injury, important approach-related complications (deltoid dehiscence and axillary nerve palsy) were observed.Level of evidence: Level IV-case series.

UI MeSH Term Description Entries

Related Publications

Eric M Padegimas, and David Merkow, and Thema A Nicholson, and Mark D Lazarus, and Matthew L Ramsey, and Gerald R Williams, and Surena Namdari
February 2023, Journal of visceral surgery,
Eric M Padegimas, and David Merkow, and Thema A Nicholson, and Mark D Lazarus, and Matthew L Ramsey, and Gerald R Williams, and Surena Namdari
November 1990, American journal of surgery,
Eric M Padegimas, and David Merkow, and Thema A Nicholson, and Mark D Lazarus, and Matthew L Ramsey, and Gerald R Williams, and Surena Namdari
November 2006, Expert review of anticancer therapy,
Eric M Padegimas, and David Merkow, and Thema A Nicholson, and Mark D Lazarus, and Matthew L Ramsey, and Gerald R Williams, and Surena Namdari
November 2006, Surgical oncology,
Eric M Padegimas, and David Merkow, and Thema A Nicholson, and Mark D Lazarus, and Matthew L Ramsey, and Gerald R Williams, and Surena Namdari
January 1993, Journal of surgical oncology,
Eric M Padegimas, and David Merkow, and Thema A Nicholson, and Mark D Lazarus, and Matthew L Ramsey, and Gerald R Williams, and Surena Namdari
June 2023, Journal of visceral surgery,
Eric M Padegimas, and David Merkow, and Thema A Nicholson, and Mark D Lazarus, and Matthew L Ramsey, and Gerald R Williams, and Surena Namdari
February 2015, Annales de dermatologie et de venereologie,
Eric M Padegimas, and David Merkow, and Thema A Nicholson, and Mark D Lazarus, and Matthew L Ramsey, and Gerald R Williams, and Surena Namdari
July 2000, Gan to kagaku ryoho. Cancer & chemotherapy,
Eric M Padegimas, and David Merkow, and Thema A Nicholson, and Mark D Lazarus, and Matthew L Ramsey, and Gerald R Williams, and Surena Namdari
April 2012, American journal of surgery,
Eric M Padegimas, and David Merkow, and Thema A Nicholson, and Mark D Lazarus, and Matthew L Ramsey, and Gerald R Williams, and Surena Namdari
October 2007, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology,
Copied contents to your clipboard!